BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32660596)

  • 21. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
    Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.
    Voges Y; Michaelis M; Rothweiler F; Schaller T; Schneider C; Politt K; Mernberger M; Nist A; Stiewe T; Wass MN; Rödel F; Cinatl J
    Cell Death Dis; 2016 Oct; 7(10):e2410. PubMed ID: 27735941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine.
    Kim H; Taslakjian B; Kim S; Tirrell MV; Guler MO
    Chembiochem; 2024 Apr; 25(8):e202300831. PubMed ID: 38408302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy.
    Yoo JD; Bae SM; Seo J; Jeon IS; Vadevoo SMP; Kim SY; Kim IS; Lee B; Kim S
    Sci Rep; 2020 Nov; 10(1):19997. PubMed ID: 33203916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges.
    Vossen LI; Markovsky E; Eldar-Boock A; Tschiche HR; Wedepohl S; Pisarevsky E; Satchi-Fainaro R; Calderón M
    Nanomedicine; 2018 Jun; 14(4):1169-1179. PubMed ID: 29471169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
    Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
    Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma.
    Jia ZY; Deng HF; Huang R; Yang YY; Yang XC; Qi ZZ; Ou XH
    Cancer Gene Ther; 2011 Mar; 18(3):196-205. PubMed ID: 21072068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
    Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
    J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.
    Groner B; Weber A; Mack L
    Bioengineered; 2012; 3(6):320-5. PubMed ID: 22825353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.
    Buursma AR; Beerens AM; de Vries EF; van Waarde A; Rots MG; Hospers GA; Vaalburg W; Haisma HJ
    J Nucl Med; 2005 Dec; 46(12):2068-75. PubMed ID: 16330572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.
    Zhang J; Spring H; Schwab M
    Cancer Lett; 2001 Oct; 171(2):153-64. PubMed ID: 11520599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.
    Arapulisamy O; Mannangatti P; Jayanthi LD
    J Biol Chem; 2013 Oct; 288(40):28599-610. PubMed ID: 23979140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells.
    Indra R; Černá T; Heger Z; Hraběta J; Wilhelm M; Dostálová S; Lengálová A; Martínková M; Adam V; Eckschlager T; Schmeiser HH; Arlt VM; Stiborová M
    Toxicology; 2019 May; 419():40-54. PubMed ID: 30914192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
    Brignole C; Bensa V; Fonseca NA; Del Zotto G; Bruno S; Cruz AF; Malaguti F; Carlini B; Morandi F; Calarco E; Perri P; Moura V; Emionite L; Cilli M; De Leonardis F; Tondo A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Moreira JN; Pastorino F
    J Exp Clin Cancer Res; 2021 Jun; 40(1):180. PubMed ID: 34078433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.
    Bauman PA; Blakely RD
    Arch Biochem Biophys; 2002 Aug; 404(1):80-91. PubMed ID: 12127072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers.
    Pastorino F; Brignole C; Di Paolo D; Perri P; Curnis F; Corti A; Ponzoni M
    Small; 2019 Mar; 15(10):e1804591. PubMed ID: 30706636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.
    Brader P; Kelly KJ; Chen N; Yu YA; Zhang Q; Zanzonico P; Burnazi EM; Ghani RE; Serganova I; Hricak H; Szalay AA; Fong Y; Blasberg RG
    Clin Cancer Res; 2009 Jun; 15(11):3791-801. PubMed ID: 19470726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications.
    Jarak I; Varela CL; Tavares da Silva E; Roleira FFM; Veiga F; Figueiras A
    Eur J Med Chem; 2020 Nov; 206():112526. PubMed ID: 32971442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.